B-cell lymphoma

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

B-cell lymphoma
Feb 23, 2025, 18:33 | Science
5 Articles suggested by Yan Leyfman
Yan Leyfman, Co-founder and Executive Director of MedNews Week, shared a few must-read papers on…
Feb 13, 2025, 06:52 | Drugs
FDA Approved Brentuximab Vedotin Combo for Relapsed/Refractory LBCL
On February 11, 2025, the FDA approved the use of brentuximab vedotin (Adcetris, Seagen Inc.,…
Feb 12, 2025, 06:48 | Blog
Ahmed Kotb: BSH 2024 Guideline on Large B-cell Lymphoma
Ahmed Kotb, Hematologist and Bone marrow transplanter at King Faisal Specialist Hospital International Holding Company,…
Feb 3, 2025, 10:33 | Science
A novel CAR T cell therapy for people with large B-cell lymphoma by Jae Park et al. - MSK Department of Medicine
MSK Department of Medicine shared a post on X about a recent paper by Jae…
Feb 1, 2025, 14:47 | Insight
MD Anderson Cancer Center's Research Highlights
Featuring novel treatment strategies for lymphomas and kidney cancers, insights into inflammatory pain, and promising…
Nov 20, 2024, 19:12 | Insight
Ajay Major: Golcadomide and R-CHOP as first line for LBCL by Arnaud Amzallag et al.
Ajay Major, Assistant Professor of Medicine at the University of Colorado School of Medicine, shared…
Nov 3, 2024, 17:05 | Insight
Vincent Rajkumar: Survival improvement in patients with HIV associated B cell lymphoma that adopted the Medicaid expansion of ACA
Vincent Rajkumar, Professor of Medicine at the Mayo Clinic in Rochester, Minnesota, shared a post…
Nov 2, 2024, 12:00 | Blog
The Latest Advances and Optimal Strategies for Peripheral T-Cell Lymphoma Treatment - Media Medic
Media Medic posted on LinkedIn: "The 5th Tianjin International Lymphoma Academic Conference, serving as an…
Oct 23, 2024, 10:00 | Insight
MD Anderson Research Highlights
Featuring novel targets for breast cancer, epigenetic strategies to improve immune responses, a treatment for…
Oct 7, 2024, 11:49 | Blog
Mohamed Benlazar: The future of immunotherapy for diffuse large B-cell lymphoma
Mohamed Benlazar, Professor of Hematology at Sidi Bel Abbès University Hospital, shared a post on…
Sep 30, 2024, 15:06 | Blog
Chul Kim: Aaron Goodman on CAR T cells for B cell lymphoma at ET24
Chul Kim posted on X: "Great talk by Aaron Goodman on CAR T cells for…
Sep 26, 2024, 12:10 | Celebrities
Jeff Bridges and Lymphoma: How He Went Against, How He Survived, and More
Jeff Bridges, the Academy Award-winning actor best known for his roles in "The Big Lebowski"…
Sep 11, 2024, 17:29 | Blog
Paper Collection on the topic "Hodgkin's Lymphomas and B-cell Lymphoma" in FBL
Cyndi Chua, Commissioning Editor at Frontiers in Bioscience-Landmark, shared a post on X: "Paper Collection…
Aug 24, 2024, 06:23 | Insight
Hematology Omission of Radiotherapy in Primary Mediastinal B-Cell Lymphoma
Raul Cordoba shared on X: “Hematology Omission of Radiotherapy in Primary Mediastinal B-Cell Lymphoma: IELSG37…
Jul 26, 2024, 08:01 | Blog
July 2024 Tip Sheet of Sylvester Comprehensive Cancer Center
This month’s tip sheet from Sylvester Comprehensive Cancer Center at the University of Miami Miller…
Jul 21, 2024, 16:40 | Insight
Hung Trinh: FDA breakthrough designation for trial of cell-based therapy for high-risk lymphoma
Hung Trinh, Director of Process Development and MFG Science and Technology at Vyriad, posted on LinkedIn:…
Jul 16, 2024, 23:11 | Blog
The role of TP53 and ctDNA kinetics in patients with R/R DLBCL
VJHemOnc (The Video Journal of Hematology and Hematological Oncology) shared a post on X: ''In…
Jul 12, 2024, 07:47 | Blog
Potential breakthrough for patients with relapsed or refractory large B-cell lymphoma - Parker Institute for Cancer Immunotherapy
Yan Leyfman, Co-Founder and Executive Director at MedNews Week,  shared a posted by Parker Institute…
Jun 27, 2024, 13:17 | Insight
Non-chemotherapy treatment regimen for aggressive B-cell lymphoma
Kimryn Rathmell shared on X: "Exciting news: NCI researchers and collaborators have developed a non-chemotherapy…
Jun 23, 2024, 14:07 | Blog
Combination Targeted Therapy in Relapsed Diffuse Large B-Cell Lymphoma
Mark Roschewski, Senior Clinician in the Lymphoid Malignancies Branch at the National Cancer Institute, shared a…
Jun 11, 2024, 14:59 | Insight
Timos Papagatsias: EHA24 is expected to be one of the most exciting EHA conferences to-date!
Timos Papagatsias, CEO of LucidQuest shared a post on LinkedIn: “EHA24 is fast approaching and…
May 24, 2024, 09:10 | Stories
William Floyd High School Unites in Honor of Rayna’s Fight Against Cancer - St. Baldrick’s Foundation
St. Baldrick’s Foundation shared a post on LinkedIn: "Cara is a long-time volunteer who lost…
May 22, 2024, 06:44 | Insight
Nausheen Ahmed: A deeper look at social determinants of health and CAR-T
Nausheen Ahmed, Medical Director of BMT Survivorship Program at The University of Kansas, shared a…
Apr 21, 2024, 18:36 | Blog
Talha Badar: Real-World and Clinical Trial Outcomes in Large B-cell Lymphoma with Axicabtagene Ciloleucel Across Race and Ethnicity
Talha Badar, Assistant Professor of Oncology at Mayo Clinic, shared a post on X: “Real-World…
Apr 17, 2024, 11:47 | Blog
The collaboration that ultimately led to a phase II clinical trial at Massachusetts General Hospital, where Serena found her miracle - St. Baldrick's Foundation
St. Baldrick's Foundation shared a post on LinkedIn: "David DiCillo (Dave) and Michael Tucker (Mike) are…
Feb 12, 2024, 01:17 | Insight
Aaron Goodman: Sorting out High Grade B-cell Lymphomas using morphology and FISH!
Aaron Goodman shared a post on X/Twitter: “Sorting out High Grade B-cell Lymphomas using morphology and…
Jan 5, 2024, 11:32 | Insight
Qiang Pan-Hammarström: We developed a new 24-gene expression score to identify high risk for developing refractory/relapsed lymphoma
Qiang Pan-Hammarström, Professor of Clinical Immunology and member of Nobel Assembly at the Karolinska Institute,…
Oct 12, 2023, 15:38 | Insight
NCCN published the first Chemotherapy Order Templates for pediatric cancer. - National Comprehensive Cancer Network (NCCN)
National Comprehensive Cancer Network (NCCN) shared on LinkedIn: “NCCN published the first Chemotherapy Order Templates…
Sep 21, 2023, 18:12 | Insight
Fiona Hamilton Marshall: These are hopeful findings for patients with relapsed/refractory diffuse large B-cell lymphomawho may not have a durable response to existing therapies.
Sep 20, 2023, 17:13 | Insight
Jeff Ryckman: How many patients make it to CAR-T without ever seeing radiotherapy?
Jeff Ryckman, Radiation Oncologist and Assistant Professor at West Virginia University shared a post by…
Sep 14, 2023, 02:57 | Insight
Michael Dickinson: In our article, we report on the development of rapid CART - YTB323, also known as rapcabtagene autoleucel.
Michael Dickinson, Haematologist at Peter MacCallum Cancer Centre, recently shared on LinkedIn: "RAPID CAR-T! Autologous…
All: 31 Posts: 1 - 100
Special Coverage